stockmarketproxy
/
BSXNYSE SEC EDGAR

BOSTON SCIENTIFIC CORP

Surgical & Medical Instruments & Apparatus·MARLBOROUGH, MA·FY end 12/31·CIK 885725
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$20.1B$16.7B$14.2B$12.7B$11.9B
Gross Profit$13.9B$11.5B$9.9B$8.7B$8.2B
Operating Income$3.6B$2.6B$2.3B$1.6B$1.2B
Net Income——————
Operating CF$4.5B$3.4B$2.5B$1.5B$1.9B
Capex$876.0M$790.0M$711.0M$588.0M$554.0M
Free Cash Flow$3.7B$2.6B$1.8B$938.0M$1.3B
Buybacks———$0$0
Dividends——————
Gross Margin69.0%68.6%69.5%68.8%68.8%
Operating Margin18.0%15.5%16.5%13.0%10.1%
Net Margin——————
FCF Margin18.2%15.8%12.6%7.4%11.1%
R&D / Revenue——————
Effective Tax14.6%19.1%19.8%38.8%3.3%
Debt / Equity——————
Buybacks / FCF———0.0%0.0%

Peer comparison

Surgical & Medical Instruments & Apparatus · 5 peers
CEO Pay Ratio
BSX
348:1
SYK
264:1
MMM
316:1
PODD
213:1
BAX
257:1
BDX
374:1
CEO total comp
BSX
$24M
SYK
$21M
MMM
$21M
PODD
$19M
BAX
$18M
BDX
$17M
Net Margin
BSX
—
SYK
11.8%
MMM
13.0%
PODD
9.1%
BAX
-8.5%
BDX
7.7%